Anemia Research Today is a free monthly online journal that collates and summarizes the latest research about Anemia, including details on symptoms, diagnosis, diet, treatment, causes.

Persistent parvovirus B19-induced anemia in an HIV-infected patient under HAART. Case report and review of literature.

Morelli P, Bestetti G, Longhi E, Parravicini C, Corbellino M, Meroni L

Institute of Infectious Diseases and Tropical Medicine, Luigi Sacco Hospital, University of Milan, Via GB Grassi 74, 20157, Milan, Italy. paola.morelli@unimi.it

Recent reports document resolution of human parvovirus B19-related pure red blood cell aplasia (PB19-PRCA) in HIV-infected patients upon commencement of highly active antiretroviral therapy (HAART). This article describes a patient with PB19-PRCA who, despite fully suppressive HAART, required cyclic administration of intravenous human immunoglobulin over a period of 17 months before PB19 seroconversion and subsequent resolution of relapsing severe anemia. All reports in the English literature describing PB19-related hematologic abnormalities in the post-HAART era are also described herein.

Published 11 October 2007 in Eur J Clin Microbiol Infect Dis, 26(11): 833-7.
Full-text of this article is available online (may require subscription).

© 2004-2008 Anemia Research Today. All Rights Reserved.